Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Aug 29;14(8):e28528.
doi: 10.7759/cureus.28528. eCollection 2022 Aug.

Sickle Cell Disease and Its Respiratory Complications

Affiliations
Review

Sickle Cell Disease and Its Respiratory Complications

Mashal I Khan et al. Cureus. .

Abstract

Sickle cell disease (SCD) is a hematological disorder that is inherited in an autosomal recessive (AR) fashion. It is caused by mutations in the genes encoding for the globin apoprotein of hemoglobin (Hb), leading to diminished oxygen-carrying ability. Its pathophysiologic mechanism affects multiple organ systems, making it crucial to understand the complications of SCD and find the best ways to prevent and treat them. Some important ways that SCD manifests in the respiratory system are acute chest syndrome (ACS), pulmonary hypertension (PH), asthma, and venous thromboembolism (VTE). This article summarizes their salient features, including pathogenesis related to the adverse outcomes, screening practices, and management guidelines, with the intent to provide greater insight into forming better practices that increase the quality of life in SCD patients.

Keywords: acute chest syndrome (acs); asthma; pulmonary; pulmonary hypertension; pulmonary screening; respiratory; sickle cell disease complications; sickle cell disease: scd; venous thromboembolism (vte).

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. Classification of Pulmonary Hypertension According to Cause

References

    1. Chronic pulmonary complications of sickle cell disease. Mehari A, Klings ES. Chest. 2016;149:1313–1324. - PMC - PubMed
    1. Sickle cell trait diagnosis: clinical and social implications. Naik RP, Haywood C Jr. Hematology Am Soc Hematol Educ Program. 2015;2015:160–167. - PMC - PubMed
    1. Population estimates of sickle cell disease in the U.S. Hassell KL. Am J Prev Med. 2010;38:0–21. - PubMed
    1. Sickle cell anemia, the first molecular disease: overview of molecular etiology, pathophysiology, and therapeutic approaches. Steinberg MH. ScientificWorldJournal. 2008;8:1295–1324. - PMC - PubMed
    1. Sickle cell disease in sub-Saharan Africa. Williams TN. Hematol Oncol Clin North Am. 2016;30:343–358. - PMC - PubMed

LinkOut - more resources